Literature DB >> 1547718

Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse.

C M Gundberg1, M E Clough, T O Carpenter.   

Abstract

The hypophosphatemic (Hyp) mouse is a model for human familial hypophosphatemic rickets. To test the hypothesis that there is an osteoblastic defect in these animals, serum osteocalcin levels were measured in Hyp mice and their normal littermates. Furthermore, the effects of phosphorus deprivation, phosphorus loading, and 1,25-dihydroxyvitamin D3 administration on serum osteocalcin levels were examined. Osteocalcin was purified from mouse hindlimbs, and a polyclonal antibody to this material was produced in a goat. The antibody recognized native and decarboxylated mouse osteocalcin, but could not recognize osteocalcin from several other species. A RIA was developed which had a minimal detection limit of 0.4 nmol/liter (2.2 micrograms/liter) and half-maximal displacement at 2.7-3.3 nmol/liter (14.8-18.2 micrograms/liter). The intraassay coefficient of variation was 6.4%, while the interassay coefficient of variation was 12%. Dilutions of mouse serum samples varied by less than 15%. Analytical recovery was typically greater than 90%. Serum osteocalcin concentrations in Hyp and normal mice were shown to decrease with age. However, circulating osteocalcin levels in Hyp mice were higher than those in their normal littermates regardless of the age of the animal (P less than 0.001). One week of a high phosphorus diet resulted in an increase in serum phosphate in normal and Hyp mice, but serum osteocalcin concentrations were unaffected. On the other hand, dietary phosphorus deprivation for 4 weeks resulted in comparable hypophosphatemia in both Hyp and normal mice, and serum osteocalcin increased in both groups of animals. Intraperitoneal injection of 30 ng/day 1,25-dihydroxyvitamin D3 for 7 days resulted in a 215 +/- 33% increase in serum osteocalcin in normal animals, while the same regimen produced a 250 +/- 29% decrease in the Hyp mouse. Our results are consistent with the hypothesis that abnormal osteoblastic activity is present in Hyp mice. Furthermore, hypophosphatemia may be a general regulator of osteocalcin synthesis or secretion in the mouse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547718     DOI: 10.1210/endo.130.4.1547718

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Authors:  Jackie A Fretz; Tracy Nelson; Yougen Xi; Douglas J Adams; Clifford J Rosen; Mark C Horowitz
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

2.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

3.  Influence of carboxylation on osteocalcin detection by mass spectrometry.

Authors:  Timothy P Cleland; Corinne J Thomas; Caren M Gundberg; Deepak Vashishth
Journal:  Rapid Commun Mass Spectrom       Date:  2016-10-15       Impact factor: 2.419

4.  Decreased sensory responses in osteocalcin null mutant mice imply neuropeptide function.

Authors:  Patricia Patterson-Buckendahl; Agnieszka Sowinska; Stephanie Yee; Dhara Patel; Stephen Pagkalinawan; Muhammad Shahid; Ankit Shah; Christopher Franz; Daniel E Benjamin; Larissa A Pohorecky
Journal:  Cell Mol Neurobiol       Date:  2012-02-17       Impact factor: 5.046

5.  Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation.

Authors:  Joshua N VanHouten; Pamela Dann; Andrew F Stewart; Christine J Watson; Michael Pollak; Andrew C Karaplis; John J Wysolmerski
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.

Authors:  Catherine A Brownstein; Junhui Zhang; Althea Stillman; Bruce Ellis; Nancy Troiano; Douglas J Adams; Caren M Gundberg; Richard P Lifton; Thomas O Carpenter
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

7.  Altered Ethanol Consumption in Osteocalcin Null Mutant Mice.

Authors:  Patricia Patterson-Buckendahl; Muhammad Shahid; Ankit Shah; Larissa A Pohorecky
Journal:  Cell Mol Neurobiol       Date:  2017-08-29       Impact factor: 5.046

8.  Ebf1-dependent control of the osteoblast and adipocyte lineages.

Authors:  David G T Hesslein; Jackie A Fretz; Yougen Xi; Tracy Nelson; Shoaming Zhou; Joseph A Lorenzo; David G Schatz; Mark C Horowitz
Journal:  Bone       Date:  2008-12-16       Impact factor: 4.398

9.  Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor.

Authors:  Taranpreet K Chandhoke; Yu-Feng Huang; Fei Liu; Gloria A Gronowicz; Douglas J Adams; John R Harrison; Barbara E Kream
Journal:  Bone       Date:  2008-03-29       Impact factor: 4.398

10.  The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.

Authors:  Tsutomu Kawano; Nancy Troiano; Douglas J Adams; Jian Jun Wu; Ben-hua Sun; Karl Insogna
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.